Low.: Clinical trials in which Bicalutamide was given as part of a combination regimen with an lhrh analog reveal that 5% of patients experienced urinary retention. In general, urinary symptoms were rare in post-marketing surveillance.
Answered 6/24/2014
5.5k views
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question